miR-30a |
Increased expression of SOX9, collagen II, and GAGs production in human chondrocytes. Protection from inflammatory stimuli (IL-1β) |
[38] |
miR-145 |
Increased expression of SOX9 in human chondrocytes |
[91] |
miR-199a |
Increased expression of SOX9, collagen II, and aggrecan in human chondrocytes and MSCs |
[93, 125] |
miR-495 |
Enhanced the TGF-β3-mediated chondrogenesis of hMSCs |
[94] |
miR-1247 |
Increased expression of SOX9 and collagen II in human chondrocytes |
[95] |
miR-194 |
Enhanced chondrogenesis of adipose tissue derived hMSCs. Increased expression of collagen II, IX, XI, aggrecan, and COMP |
[96] |
miR-34a |
Increased synthesis of cartilage ECM (collagen II, GAGs) by limb bud mesenchymal cells. Protection of human chondrocytes from inflammatory stimuli (IL-1β) |
[98, 100] |
miR-142 |
Increased cell viability, proliferation, migration and precartilage condensation of mesenchymal cells |
[99] |
miR-375 |
Increased proliferation, migration and precartilage condensation of mesenchymal cells |
[97] |
miR-99a |
Promotion of early chondrogenesis of rat MSCs with increased production of cartilage ECM (collagen II, aggrecan, GAGs) |
[101] |
miR-193b |
Increased expression of SOX9, collagen II and aggrecan in human chondrocytes |
[93] |
miR-200a |
Enhanced chondrogenesis in MCC cells and organ cultures, with increased levels of SOX9 and collagen II |
[24] |
miR-221 |
In vitro chondrogenesis of hMSCs in the absence of growth factors and without progression to hypertrophy. Enhanced hMSCs-mediated in vivo cartilage repair |
[32, 60] |
miR-222 |
Enhanced chondrogenesis and osteogenesis of hMSCs in vitro. Improved angiogenesis and bone union and healing in vivo |
[102] |
circRNA-CER |
Increased expression of collagen II and aggrecan in human OA chondrocytes. Suppression of MMP13 |
[108] |
lncRNA-CIR |
Increased expression of collagen I, II, aggrecan and GAGs production in human OA chondrocytes. Suppression of MMP13 and ADAMTS5 |
[109] |